Shizhen Zhou
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report.
Journal: Anti-cancer drugs
Published: September 29, 2025
Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Journal: Archives of biochemistry and biophysics
Published: December 05, 2023
Early diagnosis of brain metastases using cerebrospinal fluid cell-free DNA-based breakpoint motif and mutational features in lung cancer.
Journal: Clinical and translational medicine
Published: January 06, 2023
Olaparib Combined With Dacomitinib in Osimertinib-Resistant Brain and Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Report and Systematic Review.
Journal: Frontiers in oncology
Published: February 16, 2022
Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review.
Journal: Cancer biology & therapy
Published: March 28, 2020
Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study.
Journal: OncoTargets and therapy
Published: August 11, 2019
Rare NF1 Gene Mutation in Chinese Patient with Neurofibromatosis Type 1 and Anaplastic Astrocytoma.
Journal: World neurosurgery
Published: July 17, 2019
MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.
Journal: Experimental and therapeutic medicine
Published: October 30, 2016
Phase II Study of High-Dose Pemetrexed Plus Cisplatin as First-Line Chemotherapy In the Treatment of Patients with Brain Metastases from Lung Adenocarcinoma.
Journal: World neurosurgery
Published: December 08, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026